Citoxlab: Charles River Laboratories Completes the Acquisition of Citoxlab
Charles River Laboratories International, Inc. announced that it has completed the previously announced acquisition of Citoxlab for €448 million in cash, subject to customary closing adjustments.
Read full article »
CiToxLAB provides preclinical and specialty services for pharmaceutical, biotechnology, chemicals, cosmetics and medical industries.
Read more